reports
AbCellera to Report Third Quarter 2024 Financial Results on November 4...
VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) will announce its third quarter 2024 financial results on Monday, November 4, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link that will be posted on . A replay will be available through the same link following the conference call. About AbCellera Biologics Inc. (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and en...
- Jonathan Moreland
UEC URANIUM ENERGY CORP
PSEC PROSPECT CAPITAL CORPORATION
PENN PENN NATIONAL GAMING INC.
PBF PBF ENERGY INC. CLASS A
OOMA OOMA
LANC LANCASTER COLONY CORPORATION
IMMR IMMERSION CORP.
HNRG HALLADOR ENERGY CO.
GLP GLOBAL PARTNERS LP
CGNX COGNEX CORPORATION
CECE CECO ENVIRONMENTAL CORP.
DKL DELEK LOGISTICS PARTNERS
MYRG MYR GROUP INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
CIA CITIZENS INC. CL A
BRN BARNWELL INDUSTRIES
CNX CONSOL ENERGY INC.
TALO TALOS ENERGY INC.
ISDR ISSUER DIRECT CORP.
ESTC ELASTIC N.V.
CRTX CORTEXYME
ONEW ONEWATER MARINE
HPK HIGHPEAK ENERGY INC (A)
ABCL ABCELLERA BIOLOGICS
LESL LESLIES
BFLY BUTTERFLY NETWORK INC (A)
INBX INHIBRX
NN INC.
AMLX NEXTNAV INC
NXGL AMYLYX PHARMACEUTICALS INC
HR NEXGEL INC
VFC HEALTHCARE TRUST OF AMERICA INC.
CALC VF CORPORATION
SMRT CALCIMEDICA INC.
ATMU SMARTRENT INC
STCN ATMUS FILTRATION TECHNOLOGIES INC
SRBK STEEL CONNECT INC
LIFW SR BANCORP INC
DBD MSP RECOVERY INC.
SUNS DIEBOLD NIXDORF INCORPORATED
MSGE SUNRISE REALTY TRUST
XPER MSG ENTERTAINMENT SPINCO
NUTX INC.
OBDE XPERI INC
LOCO NUTEX HEALTH INC
NTG OWL ROCK CAPITAL CORP III
MRAI LOVE OIL INC.
MDRR TORTOISE MIDSTREAM ENERGY FUND INC
GDV MARPAI
INC.
MEDALIST DIVERSIFIED REIT INC.
THE GABELLI DIVIDEND & INCOME TRUST
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TCBI TEXAS CAPITAL BANCSHARES INC.
PBF PBF ENERGY INC. CLASS A
OOMA OOMA
MPAA MOTORCAR PARTS OF AMERICA INC.
LANC LANCASTER COLONY CORPORATION
IMMR IMMERSION CORP.
HNRG HALLADOR ENERGY CO.
GLP GLOBAL PARTNERS LP
FLDM FLUIDIGM
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CRK COMSTOCK RESOURCES INC.
BEN FRANKLIN RESOURCES INC.
APEI AMERICAN PUBLIC EDUCATION
ATEC ALPHATEC HOLDINGS INC.
DKL DELEK LOGISTICS PARTNERS
MYRG MYR GROUP INC.
EPD ENTERPRISE PRODUCTS PARTNERS L.P.
GBDC GOLUB CAPITAL BDC INC.
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ISDR ISSUER DIRECT CORP.
AXR AMREP
ELAN ELANCO ANIMAL HEALTH INC.
GRX THE GABELLI HEALTHCARE & WELLNESSRX TRUST
GRWG GROWGENERATION
ONEW ONEWATER MARINE
BILL BILL.COM HOLDINGS
HPK HIGHPEAK ENERGY INC (A)
ABCL ABCELLERA BIOLOGICS
LESL LESLIES
BFLY BUTTERFLY NETWORK INC (A)
INBX INHIBRX
IMMX INC.
NN IMMIX BIOPHARMA INC
NXGL NEXTNAV INC
BIGZ NEXGEL INC
PFHC BLACKROCK INNOVATION AND GROWTH TST
CALC PROFRAC HLDG CORP
ATMU CALCIMEDICA INC.
ET ATMUS FILTRATION TECHNOLOGIES INC
MIO ENERGY TRANSFER LP
PEO PIONEER MUN HIGH INCOME OPPORTUNITIES FD INC
SUNS PETROLEUM & RESOURCES CORPORATION
XPER SUNRISE REALTY TRUST
OBDE XPERI INC
LOCO OWL ROCK CAPITAL CORP III
LOVE OIL INC.
- Jonathan Moreland
MPAA MOTORCAR PARTS OF AMERICA INC.
LANC LANCASTER COLONY CORPORATION
IMMR IMMERSION CORP.
GLP GLOBAL PARTNERS LP
FLDM FLUIDIGM
CTRN CITI TRENDS INC.
APEI AMERICAN PUBLIC EDUCATION
GBDC GOLUB CAPITAL BDC INC.
BRN BARNWELL INDUSTRIES
MAV PIONEER MUNICIPAL HIGH INCOME ADVANTAGE TRUST
APPN APPIAN
MHI PIONEER MUNICIPAL HIGH INCOME TRUST
ISDR ISSUER DIRECT CORP.
AXR AMREP
UPWK UPWORK
HPK HIGHPEAK ENERGY INC (A)
ABCL ABCELLERA BIOLOGICS
NVTS NAVITAS SEMICONDUCTOR CORP
PFHC PROFRAC HLDG CORP
SRBK SR BANCORP INC
AbCellera to Present at Upcoming Investor Conferences in September
VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced that executives from the Company will be presenting at the following investor conferences: Wells Fargo Healthcare Conference on Thursday, September 5, 2024, at 12:00 p.m. Pacific Time (3:00 p.m. Eastern Time) Cantor Global Healthcare Conference on Tuesday, September 17, 2024, at 8:30 a.m. Pacific Time (11:30 a.m. Eastern Time) Live audio webcasts of each presentation may be accessed through links that will be posted on . Replays of each webcast will be available through the same links following the presenta...
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.62 per S...
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.62 per Share ANCHORAGE, Alaska, Aug. 23, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.62 per share. The dividend will be payable on September 13, 2024, to shareholders of record at the close of business on September 5, 2024. “We are pleased to announce a quarterly dividend of $0.62 per share, as we continue to provide returns to our shareholders,” said Mike Huston, President and CEO. At the stock price o...
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates ...
TELA Bio Reports Second Quarter 2024 Financial Results and Reiterates Full Year 2024 Revenue Guidance MALVERN, Pa., Aug. 12, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio"), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions today reported financial results for the second quarter ended June 30, 2024. Recent Highlights Reported revenue of $16.1 million in the second quarter, representing growth of 11% over the prior year period of 2023;Appointed Greg Firestone as Chief Commercial Officer on May 20, 2024 to drive our...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)...
TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) MALVERN, Pa., Aug. 09, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Compensation Committee of the Board of Directors of TELA Bio approved inducement grants of restricted stock units covering 16,000 shares of its common stock to nine newly-hired employees, with a grant date of August 6, 2024 (the "Grant Date"). The restricted stock units were granted purs...
AbCellera Reports Q2 2024 Business Results
VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced financial results for the second quarter of 2024. All financial information in this press release is reported in U.S. dollars, unless otherwise indicated. “This quarter, we made important progress on our internal pipeline and aim to submit applications for clinical trials for ABCL635 and ABCL575 in the second quarter of 2025. In parallel, we have focused preclinical work on our T-cell engager platform to four molecules for indications in oncology and autoimmunity,” said Carl Hansen, Ph.D., founder and CEO of AbCel...
AbCellera and Lilly Expand Collaboration to Develop Antibody Medicines
VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) announced today that it has expanded its existing collaboration with Eli Lilly and Company (Lilly) to discover therapeutic antibodies for programs in immunology, cardiovascular disease, and neuroscience. The expansion builds upon the successful research collaboration in March 2020, which included eight de novo programs for targets selected by Lilly and an exclusive license to AbCellera’s COVID-19 antibody program. AbCellera has advanced all eight programs under the original agreement, and the licensed program resulted in emergen...
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Co...
TELA Bio to Participate in the Canaccord Genuity 44th Annual Growth Conference MALVERN, Pa., July 25, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will participate in the Canaccord Genuity 44th Annual Growth Conference. TELA’s management is scheduled to present at the Canaccord Genuity 44th Annual Growth Conference at 10:30 am ET on August 14th, 2024. Interested parties can access the live and archived webcast at . About TELA Bio...
Northrim BanCorp Earns $9.0 Million, or $1.62 Per Diluted Share, in Se...
Northrim BanCorp Earns $9.0 Million, or $1.62 Per Diluted Share, in Second Quarter 2024 ANCHORAGE, Alaska, July 24, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ:NRIM) (“Northrim” or the “Company”) today reported net income of $9.0 million, or $1.62 per diluted share, in the second quarter of 2024, compared to $8.2 million, or $1.48 per diluted share, in the first quarter of 2024, and $5.6 million, or $0.98 per diluted share, in the second quarter a year ago. The increase in second quarter 2024 profitability as compared to the prior quarter and the second quarter a year ago was ...
TELA Bio to Announce Second Quarter 2024 Financial Results
TELA Bio to Announce Second Quarter 2024 Financial Results MALVERN, Pa., July 22, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (NASDAQ: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that the Company will report second quarter 2024 financial results on Monday, August 12, 2024. TELA Bio’s management will host a conference call and webcast at 4:30 p.m. ET that day to discuss the financial results and provide a corporate update. Second Quarter Earnings Conference Call and Webcast DetailsInves...
- Jonathan Moreland
PAYC PAYCOM SOFTWARE INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
NAD NUVEEN QUALITY MUNICIPAL INCOM
MDB MONGODB INC. CLASS A
PBYI INNOVATIVE ACQUISITIONS CORP
TELA TELA BIO
BIGZ BLACKROCK INNOVATION AND GROWTH TST
EP EMPIRE PETROLEUM CORP
PEO PETROLEUM & RESOURCES CORPORATION
AbCellera to Report Second Quarter 2024 Financial Results on August 6,...
VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) will announce its second quarter 2024 financial results on Tuesday, August 6, 2024, and hold an earnings conference call at 2:00 p.m. Pacific Time (5:00 p.m. Eastern Time) the same day. A live audio webcast of the earnings conference may be accessed through a link that will be posted on . A replay will be available through the same link following the conference call. About AbCellera Biologics Inc. (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabolic and...
- Jonathan Moreland
TTSH TILE SHOP HOLDINGS INC.
TGI TRIUMPH GROUP INC.
PBF PBF ENERGY INC. CLASS A
GLP GLOBAL PARTNERS LP
FFIN FIRST FINANCIAL BANKSHARES INC
CTRN CITI TRENDS INC.
CPSI COMPUTER PROGRAMS & SYSTEMS INC.
LEG LEGGETT & PLATT INCORPORATED
NSC NORFOLK SOUTHERN CORPORATION
SPWR SUNPOWER CORPORATION
CSWC CAPITAL SOUTHWEST CORP.
EVBN EVANS BANCORP INC.
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
BOMN BOSTON OMAHA
BCBP BCB BANCORP INC.
FRAF FRANKLIN FINANCIAL SERVICES CO.
ECOR ELECTROCORE
LSBK LAKE SHORE BANCORP INC.
TCPC BLACKROCK TCP CAPITAL CORP.
CBNK CAPITAL BANCORP
RRBI RED RIVER BANCSHARES
PCB PACIFIC CITY FINANCIAL CORP
HQL TEKLA LIFE SCIENCES INVESTORS
ABCL ABCELLERA BIOLOGICS
FTHM FATHOM HOLDINGS
AFCG AFC GAMMA
RSVR RESERVOIR MEDIA
TMCI INC.
NSPR TREACE MED CONCEPTS INC
TRDA INSPIREMD INC
MEGI ENTRADA THERAPEUTICS INC
GRNT MAINSTAY CBRE GBL INFRASTRUCTURE MEGATRENDS FD
WGS GRANITE RIDGE RESOURCES INC
LTH GENEDX HOLDINGS CORP.
OPAD LIFE TIME GROUP HLDGS INC
AEI OFFERPAD SOLUTIONS INC
BHRB ALSET INC.
BEEP BURKE HERBERT FINANCIAL SERVICES CORP
MOBILE INFRASTRUCTURE CORPORATION NEW
TELA Bio Appoints Jeffrey Blizard to its Board of Directors
TELA Bio Appoints Jeffrey Blizard to its Board of Directors MALVERN, Pa., June 04, 2024 (GLOBE NEWSWIRE) -- TELA Bio, Inc. ("TELA Bio") (Nasdaq: TELA), a commercial-stage medical technology company focused on providing innovative soft-tissue reconstruction solutions, today announced that it has appointed Jeffrey Blizard, the Global Head of Surgical Sales for Abiomed, a medical device technology company that operates as a stand-alone business within Johnson & Johnson's MedTech Segment, to its Board of Directors, effective June 4, 2024. "We are excited to have Jeff join our Board as we con...
- Jonathan Moreland
NCLH NORWEGIAN CRUISE LINE HOLDINGS LTD.
LEG LEGGETT & PLATT INCORPORATED
NXJ NUVEEN NEW JERSEY DIVIDEND ADVANTAGE MUNICIPAL FUND
HQL TEKLA LIFE SCIENCES INVESTORS
ABCL ABCELLERA BIOLOGICS
TMCI TREACE MED CONCEPTS INC
HUMA HUMACYTE INC
LTH LIFE TIME GROUP HLDGS INC
OPAD OFFERPAD SOLUTIONS INC
AbCellera to Present at the Goldman Sachs 45th Annual Global Healthcar...
VANCOUVER, British Columbia--(BUSINESS WIRE)-- (Nasdaq: ABCL) today announced that executives from the Company will present at the Goldman Sachs 45th Annual Global Healthcare Conference on Monday, June 10, 2024, at 12:20 p.m. Pacific Time (3:20 p.m. Eastern Time). A live audio webcast of the presentation may be accessed through a link that will be posted on . A replay will be available through the same link following the presentation. About AbCellera Biologics Inc. (Nasdaq: ABCL) discovers and develops antibody medicines for indications across therapeutic areas including cancer, metabo...
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.61 per S...
Northrim BanCorp, Inc. Declares Quarterly Cash Dividend of $0.61 per Share ANCHORAGE, Alaska, May 24, 2024 (GLOBE NEWSWIRE) -- Northrim BanCorp, Inc. (NASDAQ: NRIM) today announced that the Board of Directors declared a regular quarterly cash dividend of $0.61 per share. The dividend will be payable on June 14, 2024, to shareholders of record at the close of business on June 6, 2024. “We are pleased to announce a quarterly dividend of $0.61 per share, as we continue to provide returns to our shareholders,” said Mike Huston, President and CEO. At the stock price of $53.01 per share at the...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.